22157.jpg
Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Research Report 20254: Patient Pool Analysis, Market Size and Market Forecasts 2020-2034
February 13, 2024 09:50 ET | Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
22157.jpg
Japan Non-Alcoholic Steatohepatitis (NASH) Market Forecast 2023-2032: Emerging Therapies & Treatment Insights, Comprehensive Market Outlook, Expert & Qualitative Analyses
January 30, 2024 07:09 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ...
22157.jpg
Challenges in Non-Alcoholic Steatohepatitis (NASH) Diagnosis and Lack of Definitive Methods Hamper Market Growth Despite Rising Awareness
November 10, 2023 08:23 ET | Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential...
visiongain Logo.png
NASH Treatment & Therapeutics market is projected to grow at a CAGR of 38.6% by 2033: Visiongain
September 13, 2023 09:04 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled NASH Treatment & Therapeutics Market Report 2023-2033: Forecasts by Product Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib,...
Global Non-Alcoholic Steatohepatitis (NASH) Market
$5.5+ Billion Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel - Global Forecasts to 2028
September 08, 2023 09:53 ET | Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2023-2028" report has been added to ...
Vantage Market Research.png
Non Alcoholic Steatohepatitis (NASH) Market Size & Share to Surpass $21879 Million by 2028 | Vantage Market Research
April 04, 2023 08:31 ET | Vantage Market Research
WASHINGTON, April 04, 2023 (GLOBE NEWSWIRE) -- The Global Non Alcoholic Steatohepatitis (NASH) Market is valued at USD 1,569 Million in 2021 and is projected to reach a value of USD 21,879 Million...
Global Non-Alcoholic Steatohepatitis (NASH) Market
Global Non-Alcoholic Steatohepatitis Market Report to 2027 - Featuring Intercept Pharmaceuticals, Novartis, Siemens Healthineers and AstraZeneca Among Others
January 09, 2023 04:23 ET | Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of...
visiongain Logo.png
Global non-alcoholic fatty liver disease & NASH market is projected to reach at a market value of US$62.06 Billion by 2031: Visiongain Research Inc
April 12, 2022 10:35 ET | Visiongain Ltd
Global Non-alcoholic Fatty Liver Disease & NASH Market Forecast 2021-2031: - By Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity, Other Disease Causes) By...
AMR Logo.png
Endoscopy Devices for Obesity, Type II Diabetes and NASH Market to Garner $3.71 Billion by 2028: AMR
July 08, 2021 08:23 ET | Allied Market Research
Portland, OR, July 08, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Endoscopy Devices for Obesity, Type II Diabetes and Nash Market generate $2.63...
22157.jpg
Global NASH Market Report 2021: Market was Valued at $3,369.12 Million in 2020 - Forecast to 2026
April 13, 2021 07:13 ET | Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and...